Institutional Ownership Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE). We have compiled data on the 334 institutions that hold shares in the stock, with a total of 89.8 Million shares, which have been reported (via 13F filing form) to have a value of $2.37 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
478,904
shares
|
$12.6 Million
0.03% of portfolio
|
Q1 2025
Added 51.01%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
469,482
shares
|
$12.4 Million
0.0% of portfolio
|
Q1 2025
Added 44.17%
|
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
456,295
shares
|
$12 Million
0.06% of portfolio
|
Q1 2025
Reduced 0.06%
|
|
|
Man Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
455,148
shares
|
$12 Million
0.04% of portfolio
|
Q1 2025
Added 53.05%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
398,445
shares
|
$10.5 Million
2.67% of portfolio
|
Q1 2025
Added 1.9%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
388,661
shares
|
$10.3 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.04%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
May 14, 2025 Q1 2025 |
380,200
shares
|
$10 Million
0.05% of portfolio
|
Q1 2025
Added 0.72%
|
|
|
Cutter Capital Management, LP
New York, NY |
May 15, 2025 Q1 2025 |
379,303
shares
|
$10 Million
5.98% of portfolio
|
Q1 2025
Reduced 6.76%
|
|
|
Emerald Mutual Fund Advisers Trust
|
May 01, 2025 Q1 2025 |
340,975
shares
|
$9 Million
1.0% of portfolio
|
Q1 2025
Added 5.1%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
334,078
shares
|
$8.82 Million
0.02% of portfolio
|
Q1 2025
Reduced 68.23%
|
|
|
Avidity Partners Management LP
Dallas, TX |
May 15, 2025 Q1 2025 |
322,100
shares
|
$8.5 Million
2.62% of portfolio
|
Q1 2025
Reduced 8.49%
|
|
|
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
Frankfurt Am Main, 2M |
May 15, 2025 Q1 2025 |
311,101
shares
|
$8.21 Million
0.01% of portfolio
|
Q1 2025
Reduced 10.24%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
309,471
shares
|
$8.17 Million
0.0% of portfolio
|
Q1 2025
Added 50.38%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
304,244
shares
|
$8.03 Million
1.43% of portfolio
|
Q1 2025
Added 203.76%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
299,600
shares
|
$7.91 Million
0.02% of portfolio
|
Q1 2025
Added 17.63%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
293,374
shares
|
$7.74 Million
0.01% of portfolio
|
Q1 2025
Added 35.45%
|
|
|
Macquarie Group LTD
Australia, C3 |
May 15, 2025 Q1 2025 |
283,549
shares
|
$7.48 Million
0.01% of portfolio
|
Q1 2025
Added 0.21%
|
|
|
Trexquant Investment LP
Stamford, CT |
May 14, 2025 Q1 2025 |
268,666
shares
|
$7.09 Million
0.12% of portfolio
|
Q1 2025
Added 71.5%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
268,462
shares
|
$7.08 Million
0.07% of portfolio
|
Q1 2025
Reduced 0.41%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
May 15, 2025 Q1 2025 |
267,385
shares
|
$7.06 Million
2.55% of portfolio
|
Q1 2025
Added 16.88%
|
|
|
Schroder Investment Management Group
London, X0 |
May 13, 2025 Q1 2025 |
264,285
shares
|
$6.97 Million
0.01% of portfolio
|
Q1 2025
Reduced 29.74%
|
|
|
Legal & General Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
258,967
shares
|
$6.83 Million
0.0% of portfolio
|
Q4 2023
Reduced 71.88%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
256,549
shares
|
$6.77 Million
0.0% of portfolio
|
Q1 2025
Reduced 10.35%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
250,052
shares
|
$6.6 Million
3.03% of portfolio
|
Q3 2023
Added 212.36%
|
|
|
Privium Fund Management B.V.
|
May 08, 2025 Q1 2025 |
249,804
shares
|
$6.59 Million
2.37% of portfolio
|
Q1 2025
Reduced 3.32%
|